135 related articles for article (PubMed ID: 791573)
1. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
Stenson RL; Donion PT; Meyer JE
Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
[No Abstract] [Full Text] [Related]
2. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia.
Sovner R; Dimascio A
Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992
[No Abstract] [Full Text] [Related]
3. Amantadine in drug-induced extrapyramidal signs: a comparative study.
Ananth J; Sangani H; Noonan JP
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):323-6. PubMed ID: 239908
[TBL] [Abstract][Full Text] [Related]
4. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
Neu C; Dimascio A; Demirgian E
Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
[No Abstract] [Full Text] [Related]
5. Amantadine in extrapyramidal syndromes induced by neuroleptic drugs.
Dencker SJ; Lindberg D; Malm U
Nord Psykiatr Tidsskr; 1973; 27(1):31-4. PubMed ID: 4687749
[No Abstract] [Full Text] [Related]
6. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755
[No Abstract] [Full Text] [Related]
8. [Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs].
Bukowczyk A; Wasik A; Horodnicki J
Psychiatr Pol; 1974; 8(2):143-8. PubMed ID: 4830321
[No Abstract] [Full Text] [Related]
9. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
Ferrari P; Robotti E; Nardini M
Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
[No Abstract] [Full Text] [Related]
10. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
Merrick EM; Schmitt PP
Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
[No Abstract] [Full Text] [Related]
11. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
McEvoy JP; McCue M; Freter S
Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
[TBL] [Abstract][Full Text] [Related]
12. Management of extrapyramidal side effects induced by neuroleptics.
Tune LE; McHugh PR; Coyle JT
Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
[No Abstract] [Full Text] [Related]
13. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
Molcan J; Floreánová L; Polák L
Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
[No Abstract] [Full Text] [Related]
14. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Klett CJ; Caffey E
Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
[No Abstract] [Full Text] [Related]
15. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
Wasik A
Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
[No Abstract] [Full Text] [Related]
16. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
Dom R; Van Lommel R; Baro F
Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
[No Abstract] [Full Text] [Related]
17. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
Singh MM; Smith JM
J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
[No Abstract] [Full Text] [Related]
18. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
McEvoy JP
J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and clinical effects of amantadine in drug-induced extrapyramidal symptoms.
Greenblatt DJ; DiMascio A; Harmatz JS; Bernardo DL; Marder JE
J Clin Pharmacol; 1977; 17(11-12):704-8. PubMed ID: 336651
[TBL] [Abstract][Full Text] [Related]
20. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
